Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Standards
|
Transcatheter aortic valve implantation for aortic stenosisNICE Guidance, 2017Copyrights: © NICE 2017 All rights reserved. Subject to Notice of rightsDigital Resources/Online E-Resources |
|
2 |
Material Type: Standards
|
Intrapartum care for women with existing medical conditions or obstetric complications and their babiesNICE Guidance, 2019Copyrights: © NICE 2019 All rights reserved. Subject to Notice of rightsDigital Resources/Online E-Resources |
|
3 |
Material Type: Standards
|
Suspected neurological conditions: recognition and referralNICE Guidance, 2019Copyrights: © NICE 2019 All rights reserved. Subject to Notice of rightsDigital Resources/Online E-Resources |
|
4 |
Material Type: Standards
|
Inotersen for treating hereditary transthyretin amyloidosisNICE Guidance, 2019Copyrights: © NICE 2019 All rights reserved. Subject to Notice of rightsDigital Resources/Online E-Resources |
|
5 |
Material Type: Standards
|
Percutaneous mitral valve leaflet repair for mitral regurgitationNICE Guidance, 2019Copyrights: © NICE 2019 All rights reserved. Subject to Notice of rightsDigital Resources/Online E-Resources |
|
6 |
Material Type: Standards
|
Patisiran for treating hereditary transthyretin amyloidosisNICE Guidance, 2019Copyrights: © NICE 2019 All rights reserved. Subject to Notice of rightsDigital Resources/Online E-Resources |
|
7 |
Material Type: Standards
|
Dapagliflozin for treating chronic heart failure with reduced ejection fractionNICE Guidance, 2021Copyrights: © NICE 2021 All rights reserved. Subject to Notice of rightsDigital Resources/Online E-Resources |
|
8 |
Material Type: Standards
|
Permanent His-bundle pacemaker implantation for treating heart failureNICE Guidance, 2021Copyrights: © NICE 2021 All rights reserved. Subject to Notice of rightsDigital Resources/Online E-Resources |
|
9 |
Material Type: Standards
|
Tafamidis for treating transthyretin amyloidosis with cardiomyopathyNICE Guidance, 2021Copyrights: © NICE 2021 All rights reserved. Subject to Notice of rightsDigital Resources/Online E-Resources |
|
10 |
Material Type: Standards
|
Empagliflozin for treating chronic heart failure with reduced ejection fractionNICE Guidance, 2022Copyrights: © NICE 2022 All rights reserved. Subject to Notice of rightsDigital Resources/Online E-Resources |
|
11 |
Material Type: Standards
|
Avalglucosidase alfa for treating Pompe diseaseNICE Guidance, 2022Copyrights: © NICE 2022 All rights reserved. Subject to Notice of rightsDigital Resources/Online E-Resources |
|
12 |
Material Type: Standards
|
Dapagliflozin for treating chronic heart failure with preserved or mildly reduced ejection fractionNICE Guidance, 2023Copyrights: © NICE 2023 All rights reserved. Subject to Notice of rightsDigital Resources/Online E-Resources |
|
13 |
Material Type: Standards
|
Mavacamten for treating symptomatic obstructive hypertrophic cardiomyopathyNICE Guidance, 2023Copyrights: © NICE 2023 All rights reserved. Subject to Notice of rightsDigital Resources/Online E-Resources |